Note 8 - Accounts Receivable |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||
Accounts Receivable [Member] | ||||||||||||||||||||||||||||||||||||||||||||||
Notes to Financial Statements | ||||||||||||||||||||||||||||||||||||||||||||||
Accounts and Nontrade Receivable [Text Block] |
Note 8. Accounts Receivable
At June 30, 2024 and December 31, 2023, accounts receivable consisted of the following (in thousands):
The Company decreased the allowance for credit losses in the amount of approximately $54,000 and $0 for the six months ended June 30, 2024 and 2023, respectively.
Accounts receivable – trade, net for the Company as of January 1, 2023 and June 30, 2023 were approximately $0.4 million and $0.6 million, respectively.
|
X | ||||||||||
- Definition The entire disclosure for accounts receivable, contract receivable, receivable held-for-sale, and nontrade receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Details
|